PDLIM7 and nasopharyngeal carcinoma: LMP1 upregulation was demonstrated to confer a proliferative advantage and the ability to resist apoptosis to NPC cells, via the interaction of LMP1 with cell cycle-related molecules such as NF-κB, JNK, and phosphatidylinositide 3-kinases (PI3K) [33].